Leukemia Research
-
Publication Venue For
- Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.. 95:106385. 2020
- Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-up.. 39:406-410. 2015
- Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1 2013
- Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia. 33:e207-e209. 2009
- P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes. 33. 2009
- P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes. 33. 2009
- CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant.. 32:1061-1070. 2008
- P132 Cost of transfusion dependency among managed care patients with myelodysplastic syndromes. 31:S111-S112. 2007
- A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse.. 30:777-783. 2006
- Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels.. 30:24-28. 2006
- Reduced expression of TGF beta1RII in agnogenic myeloid metaplasia is not due to mutation or methylation.. 30:47-53. 2006
- A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.. 28:559-565. 2004
- Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis.. 28:285-294. 2004
- Bcr-Abl variants: biological and clinical aspects.. 26:713-720. 2002
- Commentary: targeting myelodysplastic syndromes.. 26:703. 2002
- Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.. 24:559-565. 2000
- Pre-clinical evaluation of SN-38 and novel camptothecin analogs against human chronic B-cell lymphocytic leukemia lymphocytes.. 23:1061-1070. 1999
- Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.. 22:215-219. 1998
- Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells.. 19:527-533. 1995
- Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.. 19:113-120. 1995
- Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts.. 18:337-346. 1994
- Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival.. 18:37-48. 1994
- A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes.. 17:873-882. 1993
- Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.. 15:1191-1196. 1991
- Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.. 14:895-903. 1990
- Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia.. 12:453-458. 1988
- Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine.. 9:1255-1261. 1985
- Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome.. 9:817-823. 1985
- Candidate counterparts of Sézary cells and adult T-cell lymphoma-leukaemia cells in normal peripheral blood: an ultrastructural study with the immunogold method and monoclonal antibodies.. 7:787-801. 1983
- Allogeneic marrow transplantation for acute leukemia in relapse.. 6:383-387. 1982
- Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation.. 6:409-412. 1982
- Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation.. 6:389-394. 1982
- Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission.. 6:395-399. 1982
- Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse.. 6:401-407. 1982
- Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia.. 6:639-648. 1982
- Effect of Methylglyoxal on Human Leukemia 60 Cell Growth: Modification of DNA, G1 Growth Arrest and Induction of Apoptosis. 20:397-405.
- Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect ® Disease Registry) and Who 2008 Recommendations 2017
- 249 CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY 2015
- P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine 2013
- P155 Arsenic trioxide (ATO) and gemtuzumab ozogamicin (GO) in high-risk MDS or AML arising from MDS 2007